查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600081

牛市場：按產品類型、應用和最終用戶分類 - 全球預測 2025-2030

Fetal Bovine Serum Market by Product Type (Charcoal Stripped FBS, Customized FBS, Dialyzed FBS), Application (Biopharmaceuticals, Cell Culture Media, Cosmetic Testing), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年牛市場價值為15.1億美元，預計到2024年將達到16.8億美元，複合年成長率為11.33%，預計到2030年將達到32億美元。

牛（FBS）是生物製藥和生命科學領域的重要成分，為體外細胞培養提供豐富的生長因子、荷爾蒙和其他必需營養素。其定義範圍從其高含量的胚胎生長促進要素到其作為哺乳動物細胞培養的培養基配方中的必需補充品。胎牛血清在細胞研究、生物技術、癌症研究以及疫苗和生物製藥製造中的廣泛應用凸顯了對胎牛血清的需求。最終用途範圍包括製藥、學術研究機構和受託研究機構等行業。推動胎牛血清市場的主要成長要素包括生物製藥生產需求的增加、細胞治療研究的進步以及農業生物技術應用的擴大。然而，潛在的成長機會在於針對特定細胞株製化胎牛血清變體，以及開發替代品來解決與動物性產品相關的倫理問題和成本。挑戰和限制包括有關動物福利的倫理問題、監管限制、批次間差異以及與生產和品管相關的高成本。探索重組血清替代品、無血清培養基配方和細胞培養基合成生物學進展等技術創新可能是未來研究和業務成長的富有成果的領域。這些創新有可能最大限度地減少道德問題、降低成本並改善安全狀況。該市場競爭激烈且分散，領先公司投資研發以提高質量，並尋求合作夥伴來開拓創新產品。為公司提供的策略建議包括專注於永續實踐、多元化籌資策略以及投資於替代品的研究和開發。克服這些挑戰並利用創新機會對於在不斷變化的胎牛血清市場格局中實現成長和保持競爭力至關重要。

主要市場統計
基準年[2023] 15.1億美元
預測年份 [2024] 16.8億美元
預測年份 [2030] 32億美元
複合年成長率（%） 11.33%

市場動態：快速發展的牛市場的關鍵市場洞察

供需的動態交互作用正在改變牛市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 增加在體外受精、人類和動物疫苗生產的應用
    • 慢性疾病流行需要廣泛的研究和藥物開發
    • 增加細胞研究和疫苗開發活動的投資
  • 市場限制因素
    • 越來越關注合成或植物血清替代品的開發
  • 市場機會
    • 細胞培養技術和方法的創新將提高胎牛血清的利用效率。
    • 活性化胎牛血清製造商、研究機構和生物製藥公司之間的合作和聯合研究
  • 市場挑戰
    • 關於動物性產品的嚴格法規和道德問題

波特五力：駕馭牛市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解牛市場的外部影響

外部宏觀環境因素對牛市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解牛市場競爭狀況

牛市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣牛市場供應商的績效評估

FPNV定位矩陣是評估牛市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了牛市場的成功之路

牛市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 體外受精，增加在人類和動物疫苗生產的應用
      • 慢性疾病流行需要廣泛的研究和藥物開發
      • 增加細胞研究和疫苗開發活動的投資
    • 抑制因素
      • 越來越關注合成或植物來源血清替代品的開發
    • 機會
      • 細胞培養技術和方法的創新提高了胎牛血清的利用效率
      • 胎牛血清製造商與研究機構或生物製藥公司之間建立新的夥伴關係和合作
    • 任務
      • 關於動物性產品的嚴格法規和道德問題
  • 市場區隔分析
    • 產品類型：對提供廣泛生長因子的客製化胎牛血清的需求不斷成長
    • 應用：隨著研發活動的擴大，牛在藥物開發和細胞培養中的重要作用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章牛市場：依產品類型

  • 碳化胎牛血清
  • 客製化胎牛血清
  • 透析胎牛血清
  • 去胞外體的FBS
  • 標準胎牛血清
  • 幹細胞認證胎牛血清

第7章牛市場：依應用分類

  • 生物製藥
    • 藥物開發
    • 疫苗生產
  • 細胞培養基
  • 化妝品測試
  • 診斷
  • 體外受精
    • 胚胎培養
    • 卵子冷凍保存
  • 研究與開發
  • 組織培養

第8章牛市場：依最終用戶分類

  • 學術/研究機構
  • 生物技術和製藥公司
  • 合約調查機構
  • 診斷實驗室
  • 醫院/診所

第9章 美洲牛市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太牛市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲牛市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 中國已向七家巴西生物技術公司開放市場，允許它們出口冷凍食品。
  • 戰略分析和建議

公司名單

  • Atlas Biologicals, Inc.
  • Bio Basic Inc.
  • Bio-Techne Corporation
  • Biofargo
  • Biosera
  • Biowest SAS
  • Capricorn Scientific
  • Corning Incorporated
  • Danaher Corporation
  • GeneTex, Inc.
  • HiMedia Laboratories Private Limited
  • Innovative Bioscience
  • Innovative Research
  • MedSupply Partners
  • Merck KGaA
  • Neuromics
  • Pan-Biotech GmbH
  • Rocky Mountain Biologicals
  • Seraglob by Bioswisstec Ltd
  • Serana Europe GmbH
  • SeraPrime, LLC
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • VWR International, LLC
  • Zen-Bio, Inc.
Product Code: MRR-4348D129FB33

The Fetal Bovine Serum Market was valued at USD 1.51 billion in 2023, expected to reach USD 1.68 billion in 2024, and is projected to grow at a CAGR of 11.33%, to USD 3.20 billion by 2030.

Fetal Bovine Serum (FBS) is a critical component in the biopharmaceutical and life sciences sectors, providing a rich source of growth factors, hormones, and other essential nutrients for in vitro cell culture. Its definition extends to being an essential supplement in media formulations for mammalian cell culture due to its high content of embryonic growth-promoting factors. The necessity of FBS is underscored by its widespread applications in cell-based research, biotechnology, cancer research, and the production of vaccines and biopharmaceuticals. The end-use scope includes industries such as pharmaceuticals, academic and research institutions, and contract research organizations, among others. Key growth factors driving the FBS market include the increasing demand for biopharmaceutical production, advancements in cell therapy research, and expanding agricultural biotechnology applications. However, potential growth opportunities lie in the customization of FBS variants tailored for specific cell lines and the development of alternatives to address ethical concerns and costs associated with animal-derived products. Challenges and limitations include ethical concerns regarding animal welfare, regulatory constraints, lot-to-lot variability, and the high cost associated with production and quality control. Exploring innovations such as recombinant serum alternatives, serum-free media formulations, and advancements in synthetic biology for cell culture media can serve as lucrative areas for future research and business growth. These innovations hold the potential to minimize ethical concerns, reduce costs, and improve safety profiles. The market is competitive yet fragmented, with major players investing in R&D for quality improvement and seeking partnerships for innovative product development. Strategic recommendations for businesses include focusing on sustainable practices, diversifying sourcing strategies, and investing in R&D for alternatives. Navigating these challenges and leveraging innovative opportunities will be crucial for capturing growth and maintaining a competitive edge in the evolving FBS market landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 1.51 billion
Estimated Year [2024] USD 1.68 billion
Forecast Year [2030] USD 3.20 billion
CAGR (%) 11.33%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Fetal Bovine Serum Market

The Fetal Bovine Serum Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing application in vitro fertilization, and human & animal vaccine production
    • Prevalence of chronic diseases necessitating extensive research and drug development
    • Increased investments in cell-based research and vaccine development activities
  • Market Restraints
    • Rising focus on the development of synthetic or plant-based serum alternatives
  • Market Opportunities
    • Innovations in cell culture technologies and methodologies enhance the utilization efficiency of FBS
    • Emerging partnerships and collaborations between FBS manufacturers and research institutions or biopharma companies
  • Market Challenges
    • Stringent regulations and ethical concerns regarding animal-derived products

Porter's Five Forces: A Strategic Tool for Navigating the Fetal Bovine Serum Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Fetal Bovine Serum Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Fetal Bovine Serum Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Fetal Bovine Serum Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Fetal Bovine Serum Market

A detailed market share analysis in the Fetal Bovine Serum Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Fetal Bovine Serum Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Fetal Bovine Serum Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Fetal Bovine Serum Market

A strategic analysis of the Fetal Bovine Serum Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fetal Bovine Serum Market, highlighting leading vendors and their innovative profiles. These include Atlas Biologicals, Inc., Bio Basic Inc., Bio-Techne Corporation, Biofargo, Biosera, Biowest SAS, Capricorn Scientific, Corning Incorporated, Danaher Corporation, GeneTex, Inc., HiMedia Laboratories Private Limited, Innovative Bioscience, Innovative Research, MedSupply Partners, Merck KGaA, Neuromics, Pan-Biotech GmbH, Rocky Mountain Biologicals, Seraglob by Bioswisstec Ltd, Serana Europe GmbH, SeraPrime, LLC, Takara Bio Inc., Thermo Fisher Scientific Inc., VWR International, LLC, and Zen-Bio, Inc..

Market Segmentation & Coverage

This research report categorizes the Fetal Bovine Serum Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Charcoal Stripped FBS, Customized FBS, Dialyzed FBS, Exosome Depleted FBS, Standard FBS, and Stem Cell Qualified FBS.
  • Based on Application, market is studied across Biopharmaceuticals, Cell Culture Media, Cosmetic Testing, Diagnostics, In-vitro Fertilization, Research & Development, and Tissue Culture. The Biopharmaceuticals is further studied across Drug Development and Vaccine Production. The In-vitro Fertilization is further studied across Embryo Culture and Oocyte Cryopreservation.
  • Based on End-User, market is studied across Academic & Research Institutions, Biotechnology & Pharmaceutical Companies, Contract Research Organizations, Diagnostic Laboratories, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing application in vitro fertilization, and human & animal vaccine production
      • 5.1.1.2. Prevalence of chronic diseases necessitating extensive research and drug development
      • 5.1.1.3. Increased investments in cell-based research and vaccine development activities
    • 5.1.2. Restraints
      • 5.1.2.1. Rising focus on the development of synthetic or plant-based serum alternatives
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovations in cell culture technologies and methodologies enhance the utilization efficiency of FBS
      • 5.1.3.2. Emerging partnerships and collaborations between FBS manufacturers and research institutions or biopharma companies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations and ethical concerns regarding animal-derived products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Increasing need for customized FBS offering a broad range of growth factors
    • 5.2.2. Application: Essential role of fetal bovine serum for drug development and cell culture with expanding research and development activities
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Fetal Bovine Serum Market, by Product Type

  • 6.1. Introduction
  • 6.2. Charcoal Stripped FBS
  • 6.3. Customized FBS
  • 6.4. Dialyzed FBS
  • 6.5. Exosome Depleted FBS
  • 6.6. Standard FBS
  • 6.7. Stem Cell Qualified FBS

7. Fetal Bovine Serum Market, by Application

  • 7.1. Introduction
  • 7.2. Biopharmaceuticals
    • 7.2.1. Drug Development
    • 7.2.2. Vaccine Production
  • 7.3. Cell Culture Media
  • 7.4. Cosmetic Testing
  • 7.5. Diagnostics
  • 7.6. In-vitro Fertilization
    • 7.6.1. Embryo Culture
    • 7.6.2. Oocyte Cryopreservation
  • 7.7. Research & Development
  • 7.8. Tissue Culture

8. Fetal Bovine Serum Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutions
  • 8.3. Biotechnology & Pharmaceutical Companies
  • 8.4. Contract Research Organizations
  • 8.5. Diagnostic Laboratories
  • 8.6. Hospitals & Clinics

9. Americas Fetal Bovine Serum Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Fetal Bovine Serum Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Fetal Bovine Serum Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. China opens market to Brazilian biotech firms by authorizing seven companies to export frozen fetal bovine serum
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Atlas Biologicals, Inc.
  • 2. Bio Basic Inc.
  • 3. Bio-Techne Corporation
  • 4. Biofargo
  • 5. Biosera
  • 6. Biowest SAS
  • 7. Capricorn Scientific
  • 8. Corning Incorporated
  • 9. Danaher Corporation
  • 10. GeneTex, Inc.
  • 11. HiMedia Laboratories Private Limited
  • 12. Innovative Bioscience
  • 13. Innovative Research
  • 14. MedSupply Partners
  • 15. Merck KGaA
  • 16. Neuromics
  • 17. Pan-Biotech GmbH
  • 18. Rocky Mountain Biologicals
  • 19. Seraglob by Bioswisstec Ltd
  • 20. Serana Europe GmbH
  • 21. SeraPrime, LLC
  • 22. Takara Bio Inc.
  • 23. Thermo Fisher Scientific Inc.
  • 24. VWR International, LLC
  • 25. Zen-Bio, Inc.

LIST OF FIGURES

  • FIGURE 1. FETAL BOVINE SERUM MARKET RESEARCH PROCESS
  • FIGURE 2. FETAL BOVINE SERUM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FETAL BOVINE SERUM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS FETAL BOVINE SERUM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS FETAL BOVINE SERUM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES FETAL BOVINE SERUM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES FETAL BOVINE SERUM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC FETAL BOVINE SERUM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC FETAL BOVINE SERUM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FETAL BOVINE SERUM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FETAL BOVINE SERUM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. FETAL BOVINE SERUM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. FETAL BOVINE SERUM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FETAL BOVINE SERUM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FETAL BOVINE SERUM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FETAL BOVINE SERUM MARKET DYNAMICS
  • TABLE 7. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY CHARCOAL STRIPPED FBS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY CUSTOMIZED FBS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY DIALYZED FBS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY EXOSOME DEPLETED FBS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY STANDARD FBS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY STEM CELL QUALIFIED FBS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY CELL CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY COSMETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY EMBRYO CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY OOCYTE CRYOPRESERVATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY TISSUE CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS FETAL BOVINE SERUM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES FETAL BOVINE SERUM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC FETAL BOVINE SERUM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. JAPAN FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. MALAYSIA FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 101. MALAYSIA FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. PHILIPPINES FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 106. PHILIPPINES FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SINGAPORE FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 111. SINGAPORE FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. SOUTH KOREA FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 115. SOUTH KOREA FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 116. SOUTH KOREA FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. TAIWAN FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 120. TAIWAN FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 121. TAIWAN FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. THAILAND FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 125. THAILAND FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 126. THAILAND FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. VIETNAM FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 130. VIETNAM FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 131. VIETNAM FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA FETAL BOVINE SERUM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. DENMARK FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 141. DENMARK FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 142. DENMARK FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. EGYPT FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 146. EGYPT FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 147. EGYPT FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FINLAND FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 151. FINLAND FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 152. FINLAND FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. FRANCE FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 156. FRANCE FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 157. FRANCE FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. GERMANY FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 161. GERMANY FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 162. GERMANY FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ISRAEL FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 166. ISRAEL FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 167. ISRAEL FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. ITALY FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 171. ITALY FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 172. ITALY FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NETHERLANDS FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 176. NETHERLANDS FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 177. NETHERLANDS FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NIGERIA FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 181. NIGERIA FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 182. NIGERIA FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. NORWAY FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 186. NORWAY FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 187. NORWAY FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. POLAND FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 191. POLAND FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 192. POLAND FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. QATAR FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 196. QATAR FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 197. QATAR FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. RUSSIA FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 201. RUSSIA FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 202. RUSSIA FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SAUDI ARABIA FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 206. SAUDI ARABIA FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 207. SAUDI ARABIA FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH AFRICA FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH AFRICA FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 212. SOUTH AFRICA FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SPAIN FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 216. SPAIN FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 217. SPAIN FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWEDEN FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 221. SWEDEN FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWEDEN FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. SWITZERLAND FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 226. SWITZERLAND FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 227. SWITZERLAND FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. TURKEY FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 231. TURKEY FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 232. TURKEY FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED ARAB EMIRATES FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED ARAB EMIRATES FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM FETAL BOVINE SERUM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM FETAL BOVINE SERUM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED KINGDOM FETAL BOVINE SERUM MARKET SIZE, BY BIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM FETAL BOVINE SERUM MARKET SIZE, BY IN-VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 242. UNITED KINGDOM FETAL BOVINE SERUM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. FETAL BOVINE SERUM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 244. FETAL BOVINE SERUM MARKET, FPNV POSITIONING MATRIX, 2023